ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,967Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 154

$1.42M Total Retail Price of All Prescriptions

Rank: 4 out of 154

564 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 564 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

17% of this provider’s 564 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 18,535 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 58%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $167 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
PRAVASTATIN SODIUM 963 710 1 26
OMEPRAZOLE 868 643 2 12
FUROSEMIDE 805 647 3 11
LISINOPRIL 784 585 4 17
LEVOTHYROXINE SODIUM 674 507 5 24
WARFARIN SODIUM 671 539 6 22
AMLODIPINE BESYLATE 602 453 7 18
SIMVASTATIN 596 486 8 21
POTASSIUM CHLORIDE 551 388 9 23
METFORMIN HCL 444 260 10 25
HYDROCODONE-ACETAMINOPHEN 399 278 S3 11 19
CLONIDINE HCL 387 234 12 46
ZETIA 344 257 13 51
GABAPENTIN 331 233 14 34
CITALOPRAM HBR 321 238 15 41
DONEPEZIL HCL 318 294 16 43
METOPROLOL TARTRATE 311 262 17 32
FLUTICASONE PROPIONATE 300 185 18 9
AZITHROMYCIN 298 201 19 7
PANTOPRAZOLE SODIUM 277 204 20 45
HYDROCHLOROTHIAZIDE 271 181 21 38
TRAMADOL HCL 267 180 22 37
TAMSULOSIN HCL 248 194 23 58
GLIMEPIRIDE 243 166 24 65
LANTUS 243 164 24 64
ZOLPIDEM TARTRATE 220 108 26 20
ATENOLOL 218 153 27 57
POLYETHYLENE GLYCOL 3350 209 127 28 61
NEXIUM 205 102 29 40
MIRTAZAPINE 204 152 30 85
QUETIAPINE FUMARATE 203 170 31 86
SPIRIVA 199 131 32 1
METOPROLOL SUCCINATE 195 172 33 47
NAMENDA 194 183 34 69
DILTIAZEM 24HR CD 194 160 34 88
JANUVIA 182 109 36 71
PRAMIPEXOLE DIHYDROCHLORIDE 177 123 37 30
LEVOFLOXACIN 172 119 38 15
CLOPIDOGREL 172 136 38 60
ATORVASTATIN CALCIUM 168 146 40 54
SERTRALINE HCL 165 126 41 78
NIASPAN 165 135 41 93
CYCLOBENZAPRINE HCL 164 77 R 43 72
LOVAZA 162 103 44 94
LOSARTAN POTASSIUM 158 125 45 70
ALLOPURINOL 155 142 46 62
CRESTOR 153 98 47 59
DIGOXIN 149 129 48 63
CARVEDILOL 149 121 48 55
PROAIR HFA 148 81 50 3
TRAZODONE HCL 147 105 51 50
DIVALPROEX SODIUM 145 129 52 84
PREDNISONE 141 86 53 4
HUMULIN R 140 103 54 102
COMBIVENT 134 102 55 10
RANITIDINE HCL 132 93 56 42
INSULIN SYRINGE 129 96 57 107
LOVASTATIN 128 93 58 49
ALENDRONATE SODIUM 125 82 59 76
GLYBURIDE 121 88 R 60 87
SINGULAIR 119 68 61 8
NASONEX 117 46 62 35
THEOPHYLLINE ANHYDROUS 115 68 63 13
PLAVIX 115 84 63 77
ADVAIR DISKUS 114 101 65 2
BYSTOLIC 113 111 66 82
FENOFIBRATE 106 101 67 117
BENAZEPRIL HCL 106 80 67 117
MELOXICAM 105 54 69 67
SEROQUEL 104 77 70 119
ANTARA 100 53 71 120
PROMETHAZINE HCL 97 22 R 72 92
PAROXETINE HCL 94 59 73 123
KLOR-CON 10 93 73 74 80
NYSTATIN 87 66 75 98
CARBIDOPA-LEVODOPA 85 67 76 104
CIPROFLOXACIN HCL 83 62 77 31
RISPERIDONE 83 69 77 103
RAMIPRIL 83 62 77 105
FINASTERIDE 80 68 80 130
ISOSORBIDE MONONITRATE ER 78 55 81 73
FLUOXETINE HCL 78 49 81 95
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 51 83 44
ROPINIROLE HCL 76 27 84 33
SYMBICORT 76 29 84 5
CLOTRIMAZOLE-BETAMETHASONE 74 59 86 109
AMITRIPTYLINE HCL 74 47 R 86 100
DIOVAN 72 54 88 96
DOXAZOSIN MESYLATE 70 43 89 135
PREMARIN 69 21 R 90 136
AMLODIPINE BESYLATE-BENAZEPRIL 69 44 90 100
CYMBALTA 68 55 92 108
LABETALOL HCL 66 41 93 140
SYNTHROID 66 51 93 111
SPIRONOLACTONE 66 45 93 52
AMOX TR-POTASSIUM CLAVULANATE 66 31 93 29
TRILIPIX 65 49 97 141
FAMOTIDINE 62 57 98 83
BUSPIRONE HCL 62 48 98 146
DOXYCYCLINE HYCLATE 60 41 100 16
MONTELUKAST SODIUM 59 31 101 14
LEVEMIR 58 57 102 147
PHENYTOIN SODIUM EXTENDED 58 36 102 147
IBUPROFEN 57 27 104 150
ESCITALOPRAM OXALATE 57 49 104 110
METOLAZONE 57 33 104 150
HYDRALAZINE HCL 56 46 107 91
LACTULOSE 55 29 108 156
LOSARTAN-HYDROCHLOROTHIAZIDE 54 47 109 89
OXYCODONE-ACETAMINOPHEN 52 47 S2 110 159
IMIPRAMINE HCL 52 14 R 110 159
AMOXICILLIN 52 38 110 159
VENTOLIN HFA 51 20 113 6
MECLIZINE HCL 51 36 113 162
DEXILANT 50 25 115 164
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.